Investigational monoclonal antibodies in early development for psoriatic arthritis: beyond the biosimilars.

Edwards, Anna; Chandran, Vinod; Rahman, Proton

Edwards, Anna; Chandran, Vinod; Rahman, Proton.

Afiliação

Edwards A; Faculty of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Chandran V; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada.
Rahman P; Department of Medicine, Division of Rheumatology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.

Expert Opin Investig Drugs ; 32(8): 741-753, 2023.

Article em En | MEDLINE | ID: mdl-37655430

Assuntos

Artrite Psoriásica; Medicamentos Biossimilares; Psoríase; Humanos; Artrite Psoriásica/tratamento farmacológico; Artrite Psoriásica/patologia; Anticorpos Monoclonais/efeitos adversos; Medicamentos Biossimilares/efeitos adversos; Psoríase/tratamento farmacológico; Interleucina-23

Palavras-chave

Psoriatic arthritis; immune checkpoint agonist; interleukin-17 antagonists; interleukin-23 antagonists; monoclonal antibodies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Artrite Psoriásica / Medicamentos Biossimilares Limite: Humans Idioma: En Revista: Expert Opin Investig Drugs Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google